Celera Genomics Group (NYSE:CRA - News), an Applera Corporation business, today reported a net loss of $13.6 million, or $0.19 per share, for the second quarter of fiscal 2004 ended December 31, 2003, compared to a net loss of $16.1 million, or $0.23 per share, in the second quarter of fiscal 2003. All per share amounts refer to Applera Corporation-Celera Genomics Group Common Stock. At December 31, 2003, the Group’s cash and short-term investments were approximately $770 million, compared to $790 million at September 30, 2003.
